Shanghai Kai Kai Industry Co Ltd B (900943) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Kai Kai Industry Co Ltd B (900943) has a cash flow conversion efficiency ratio of 0.007x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.04 Million) by net assets ($582.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Shanghai Kai Kai Industry Co Ltd B for the company's overall valuation and market capitalisation.
Shanghai Kai Kai Industry Co Ltd B - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Shanghai Kai Kai Industry Co Ltd B's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Kai Kai Industry Co Ltd B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Kai Kai Industry Co Ltd B ranked by their cash flow conversion efficiency. Explore 900943 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Accentis
BR:ACCB
|
0.043x |
|
Lotte Chilsung Beverage Co Ltd
KO:005305
|
0.059x |
|
Hipay Group SA
PA:ALHYP
|
0.086x |
|
Compal Broadband Networks Inc
TW:6674
|
-0.187x |
|
Artea SA
PA:ARTE
|
-0.078x |
|
Reckon Ltd
AU:RKN
|
0.538x |
|
Wiseway Group Ltd
AU:WWG
|
0.271x |
|
EMEK Elektrik Endustrisi AS
IS:EMKEL
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Shanghai Kai Kai Industry Co Ltd B (2015–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Kai Kai Industry Co Ltd B from 2015 to 2024. View Shanghai Kai Kai Industry Co Ltd B (900943) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $648.99 Million | $-61.57 Million | -0.095x | -10059.10% |
| 2023-12-31 | $607.20 Million | $578.43K | 0.001x | -99.31% |
| 2022-12-31 | $578.25 Million | $79.34 Million | 0.137x | +180.72% |
| 2021-12-31 | $546.54 Million | $26.71 Million | 0.049x | -68.83% |
| 2020-12-31 | $520.80 Million | $81.66 Million | 0.157x | +293.46% |
| 2019-12-31 | $520.14 Million | $20.73 Million | 0.040x | -37.75% |
| 2018-12-31 | $501.05 Million | $32.07 Million | 0.064x | -55.75% |
| 2017-12-31 | $502.22 Million | $72.65 Million | 0.145x | +533.88% |
| 2016-12-31 | $493.89 Million | $11.27 Million | 0.023x | -2.85% |
| 2015-12-31 | $518.11 Million | $12.17 Million | 0.023x | -- |
About Shanghai Kai Kai Industry Co Ltd B
Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company engages in the wholesale and retail of traditional Chinese and Western medicines; medical devices; reagents; consumables and diagnosis; and treatment services, etc. under the Shang Lei brand, as well as production and sale of Chinese patent medicine under the Jing and Que… Read more